Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
American Healthcare REIT (AHR)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
$56.04-0.59%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.79 → 0.78 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AHR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Normalized Funds From Operations per diluted share of at least $2.03 in FY26 | It raised normalized funds from operations per share guidance to $2.03 to $2.09. | Intact | NFFO per diluted share falls below $2.03 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “"NFFO per diluted share is now expected to be between $2.15 to $2.19 in 2026, which would translate to over 25% per share growth versus 2025.” “• The Company is increasing total portfolio Same-Store NOI growth guidance to 9.0% to 12.0% and NFFO per diluted share guidance to $2.03 to $2.09 for the year ending December 31, 2026.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
AHR is a growth-oriented real estate investment with recent operating momentum, rather than a proven earnings compounder, since it remains loss-making. Its long-term thesis is intact and the signal has turned mildly favorable, but confidence is medium and management execution has been volatile.
AHR trades at a 2.13 premium to peers, and the valuation evidence classifies it as expensive. The priced-in tag is justified, with low measured fragility, but the expectations gap is negative and the valuation model has low confidence.
Near-term operating results are strong: same-store NOI growth reached 13.2% in 2026-Q2, and management raised full-year guidance. The midpoint of 2026 NFFO per diluted share guidance also rose to $2.17, while SHOP acquisitions show continued expansion; however, recent misses and a CFO transition add execution risk.
The multi-year thesis depends on management sustaining raised guidance and translating SHOP expansion into continued operating growth. Near term, another guidance cut after recent increases could damage credibility, while Fed rate cuts would support the sector; weakness at real estate peers could remove that support.
Over the next 1 to 3 years, AHR’s operating momentum supports an intact thesis, but losses, execution uncertainty, and an expensive valuation leave limited room for disappointment. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Quarterly dividend maintained at $0.25 per share | The company keeps paying a steady $0.25 quarterly dividend. | Intact | Dividend per share falls below $0.25 in any quarter of 2026 | Dividend per share: $0.25 per share FY2026-Q2; GAAP. Published target: >=0.25 USD per share. The target does not explicitly identify fiscal versus calendar quarters. Aug 7, 20260.25 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Same-Store Net Operating Income growth of at least 9% in FY26 | American Healthcare REIT grows same-store NOI about 9% to 12% in 2026. | Intact | Same-Store NOI growth falls below 9.0% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “"That approach produced our tenth consecutive quarter of double-digit Same-Store NOI growth.” “"Same-Store occupancy gains year-over-year, dynamic revenue management, and expense discipline turned into 20.5% same-store NOI growth in SHOP and 16.1% in ISHC.” Delivery assessment Nov 4, 2026 |
Senior Housing Operating Properties acquisitions of at least $160 million in Q1 2026 | It expands its senior housing portfolio with over $160 million in recent acquisitions. | Intact | SHOP acquisitions fall below $160 million in Q1 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “We combined that strong organic growth with over $1.4 billion in new investments year-to-date.” “Following the Company’s completed transaction activity during the three months ended March 31, 2026, and subsequent to quarter end, the Company’s investments pipeline consists of over $650 million which includes newly awarded deals and deals in the pipeline previously disclosed in the Company’s Fourth Quarter 2025 Earnings Release that have yet to close.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.86 → $0.78 · observed estimates
$3.05B → $3.15B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-25 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-26 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-27 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-28 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-29 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-30 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-07-31 | $0.81 | $2,908,339,722 | 3 / 4 |
| 2026-08-01 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-02 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-03 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-04 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-05 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-06 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-07 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-08 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-09 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-10 | $0.86 | $3,054,086,970 | 2 / 6 |
| 2026-08-11 | $0.86 | $3,006,557,560 | 2 / 5 |
| 2026-08-12 | $0.90 | $3,024,937,560 | 1 / 5 |
| 2026-08-13 | $0.90 | $3,024,937,560 | 1 / 5 |
| 2026-08-14 | $0.81 | $2,908,339,722 | 3 / 4 |
| 2026-08-15 | $0.81 | $2,908,339,722 | 3 / 4 |
| 2026-08-16 | $0.81 | $2,908,339,722 | 3 / 4 |
| 2026-08-17 | $0.81 | $2,908,339,722 | 3 / 4 |
| 2026-08-18 | $0.81 | $2,908,339,722 | 3 / 4 |
| 2026-08-19 | $0.81 | $2,908,339,722 | 3 / 5 |
| 2026-08-20 | $0.81 | $2,908,339,722 | 3 / 5 |
| 2026-08-21 | $0.81 | $3,082,052,980 | 3 / 5 |
| 2026-08-22 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-23 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-24 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-25 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-26 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-27 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-28 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-29 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-30 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-08-31 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-09-01 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-09-02 | $0.79 | $3,082,052,980 | 3 / 5 |
| 2026-09-03 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-04 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-05 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-06 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-07 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-08 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-09 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-10 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-11 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-12 | $0.79 | $3,083,651,998 | 3 / 5 |
| 2026-09-13 | $0.79 | $3,083,655,998 | 3 / 5 |
| 2026-09-14 | $0.79 | $3,083,655,998 | 3 / 5 |
| 2026-09-15 | $0.79 | $3,097,983,270 | 3 / 5 |
| 2026-09-16 | $0.79 | $3,097,983,270 | 3 / 5 |
| 2026-09-17 | $0.79 | $3,097,983,270 | 3 / 5 |
| 2026-09-18 | $0.79 | $3,097,983,270 | 3 / 5 |
| 2026-09-19 | $0.79 | $3,097,983,270 | 3 / 5 |
| 2026-09-20 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-21 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-22 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-23 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-24 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-25 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-26 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-27 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-28 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-29 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-09-30 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-10-01 | $0.79 | $3,098,521,425 | 3 / 5 |
| 2026-10-02 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-03 | $0.79 | $3,100,495,604 | 3 / 5 |
| 2026-10-04 | $0.79 | $3,100,495,604 | 3 / 5 |
| 2026-10-05 | $0.79 | $3,100,495,604 | 3 / 5 |
| 2026-10-06 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-07 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-08 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-09 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-10 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-11 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-12 | $0.79 | $3,100,526,095 | 3 / 5 |
| 2026-10-13 | $0.79 | $3,100,526,095 | 3 / 4 |
| 2026-10-14 | $0.78 | $3,151,090,587 | 3 / 4 |
| 2026-10-15 | $0.78 | $3,151,090,587 | 3 / 4 |
| 2026-10-16 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-17 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-18 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-19 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-20 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-21 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-22 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-23 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-24 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-25 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-26 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-27 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-28 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-29 | $0.78 | $3,151,090,587 | 3 / 5 |
| 2026-10-30 | $0.78 | $3,151,062,637 | 3 / 5 |
| 2026-10-31 | $0.78 | $3,151,062,637 | 3 / 5 |
| 2026-11-01 | $0.78 | $3,151,062,637 | 3 / 5 |
| 2026-11-02 | $0.78 | $3,151,062,637 | 3 / 5 |
| 2026-11-03 | $0.78 | $3,151,062,637 | 3 / 5 |
| 2026-11-04 | $0.78 | $3,151,062,637 | 3 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 16 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
0 raises · 1 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.